diabetes

As for Abbott's Libre, 'You Ain't Seen Nothin' Yet'
As for Abbott's Libre, 'You Ain't Seen Nothin' Yet'
Medical Devices and Diagnostics Industry
Abbott Labs
Miles White
devices
FreeStyle Libre
blood glucose monitoring
diabetes
Flag link:
3 Top Diabetes Stocks to Watch in July
3 Top Diabetes Stocks to Watch in July
Motley Fool
diabetes
devices
DexCom
Insulet
Tandem Diabetes Care
Flag link:
Semma steps toward the clinic after demonstrating effect of potential diabetes cure in landmark animal studies
Semma steps toward the clinic after demonstrating effect of potential diabetes cure in landmark animal studies
Endpoints
Semma Therapeutics
diabetes
Flag link:
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Flag link:
Novo Nordisk goes for broke on semaglutide heart data
Novo Nordisk goes for broke on semaglutide heart data
Biopharma Dive
Novo Nordisk
diabetes
FDA
Ozempic
oral semaglutide
Flag link:
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
ADA
diabetes
Tradjenta
Flag link:
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Sanofi
diabetes
ADA
Soliqua
clinical trials
Flag link:
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Flag link:
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Flag link:
Why Diabetes Stock Insulet Soared 27.3% in May
Why Diabetes Stock Insulet Soared 27.3% in May
Motley Fool
Insulet
diabetes
devices
Omnipod
Flag link:
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
Flag link:
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
Xconomy
diabetes
microbiome
Whole Biome
Flag link:
Even as obesity rates climb, new diabetes cases fall
Even as obesity rates climb, new diabetes cases fall
Stat
diabetes
obesity
Flag link:
Factors behind $41 billion Diabetes Care Devices Market growth, by 2025
Factors behind $41 billion Diabetes Care Devices Market growth, by 2025
Pharmaforum
diabetes
devices
Flag link:
Colorado becomes first state to cap out-of-pocket insulin costs
Colorado becomes first state to cap out-of-pocket insulin costs
The Hill
Colorado
insulin
drug pricing
co-pays
diabetes
Flag link:
Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart
BioSpace
Eli Lilly
drug pricing
generics
insulin
diabetes
Lispro
KwikPens
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
diabetes
heart disease
cardiometabolic health
heart failure
Flag link:
3 Top Diabetes Stocks to Watch in May
3 Top Diabetes Stocks to Watch in May
Motley Fool
diabetes
AstraZeneca
Eli Lilly
Medtronic
Flag link:
Interchangeable Insulins: FDA Holds Public Meeting
Interchangeable Insulins: FDA Holds Public Meeting
RAPS.org
diabetes
insulin
biosimilars
FDA
biosimilar insulin
Flag link:

Pages